Morgan Stanley raised its price target for Cardinal Health on August 8, 2025.
2 reports, 2 independent
Updated Jun 16
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley raised its price target for Cardinal Health on August 8, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Morgan Stanley boosted its price objective on Cardinal Health stock.1 source
Morgan Stanley raised the price target for Cardinal Health.1 source
Keep exploring
The entities involved
-
Morgan Stanley
U.S. investment bank
-
Cardinal Health
Healthcare company
Related events
- Morgan Stanley increased its target price for Garmin Ltd. on October 6, 2026.
- Morgan Stanley adjusted its price target for Citizens Financial Group on July 3, 2025.
- Morgan Stanley set a $38.00 target price for Kinder Morgan on August 16, 2026.
- HSBC provided a buy rating and price target for Johnson & Johnson, while Morgan Stanley raised its price objective to $294.00. The company also filed required 13F reports with the SEC.
- Royal Bank of Canada, Bank of America, and Morgan Stanley raised price targets for argenex.
Coverage
Newest first; wire copies grouped- themarketsdaily.com
- BarchartDo Wall Street Analysts Like Cardinal Health Stock? With a market cap of $37.4 billion, Cardinal Health, Inc. (CAH) is a leading Ohio-based healthcare services and products company specializing in ph